VERAXA and Secarna Report Positive Early Data for AOCs in Autoimmune Diseases
August 24, 2026 — VERAXA Biotech and Secarna announce positive initial results for AOCs in autoimmune diseases, showing greater potency in vitro. This collaboration could lead to new treatments.